Lorcaserin Diet Pills

by Diet Pill Center on August 6, 2012

belviq

[starratingmulti id=1 tpl=12]

Lorcaserin, a prescription weight loss drug also known as BELVIQ and which was created by Arena Pharmaceuticals, has just received its approval by the FDA, becoming the first medication of this nature to receive the nod from the U.S. Food and Drug Administration since 1999. This drug had previously been denied its approval application in December 2010, following an association between its use and tumors in rats, and because the weight loss that it encouraged was deemed to be negligible and that patients in clinical trials regained any weight that they did lose once the use of the drug was terminated.

After their initial failure to receive approval Arena Pharmaceuticals cut a quarter of its jobs in the United States in order to be able to save adequate money to follow the recommendations of the FDA and further the testing on Lorcaserin.

The newly approved Lorcaserin drug functions as an appetite suppressant. Though there are already a number of other FDA approved prescription medications that work in the same way, the testing from Arena Pharmaceuticals has suggested that this new drug is different in that it can be used with a lower risk of potential side effects when compared to the other options on the market. Equally, research has also indicated that among the few side effects that are associated with the use of this drug, some are more severe than those of its competition.

Through the last year and a half Arena Pharmaceuticals managed to conduct additional testing that showed to the FDA that the use of Lorcaserin is safe for humans, and that the risks that do exist are minimal enough to make the benefits well worth it.

Like the other prescription weight loss drugs currently on the market, Lorcaserin is available only to patients who have been diagnosed with clinical obesity. It is meant to help to reduce the excess weight when diet and exercise alone have been insufficient. This, in turn, will reduce the risk of other health conditions connected with the patient’s obesity, such as high cholesterol, high blood pressure, diabetes, some cancers, and others.

The Lorcaserin drug will not be prescribed to an individual who is not sufficiently overweight, as the lack of excess body fat will increase the risk and severity of serious side effects. Moreover, a lower calorie diet and an exercise program will be prescribed in conjunction with this medication, as it will not cause fat to be lost without these additional efforts.

{ 0 comments… add one now }

Leave a Comment

Previous post:

Next post: